REPORT: Trump Offered $1 Billion For German Vaccine

The Guardian reports:

German ministers have reacted angrily following reports US president Donald Trump offered a German medical company “large sums of money” for exclusive rights to a Covid-19 vaccine. “Germany is not for sale,” economy minister Peter Altmaier told broadcaster ARD, reacting to a front page report in Welt am Sonntag newspaper headlined “Trump vs Berlin”. The newspaper reported Trump offered $1bn to pharmaceutical company CureVac to secure the vaccine “only for the United States”.

Christian Lindner, leader of the liberal FDP party, accused Trump of electioneering, saying: “Obviously Trump will use any means available in an election campaign.” Last week, the firm mysteriously announced that CureVac CEO Daniel Menichella had been replaced by Ingmar Hoerr, just weeks after Menichella met Trump, his vice-president Mike Pence and representatives of pharma companies in Washington.

CNBC reports:

White House trade advisor Peter Navarro told CNBC on Monday that he’s preparing an executive order that would help relocate medical supply chains from overseas to the U.S. German government sources told Reuters on Sunday the Trump administration was looking into how it could gain access to a potential vaccine being developed by a German firm, CureVac.

Navarro, in a “Squawk Box” interview, brushed off a question about the administration’s reported overtures toward CureVac and instead spoke about the general need to manufacture more medical equipment and supplies in the U.S. “What I can speak to is this broader, interesting issue of how dependent the US is on the global supply chain, not just for its medicines but for its medical supplies and medical equipment,” Navarro said.

Read the full article.